APA (7th ed.) Citation

Jin, F., Wang, C., Yang, F., Wang, S., & Wang, F. Case Report: Successful late-line pralsetinib treatment in an ALK-rearranged lung adenocarcinoma patient with KIF5B-RET fusion resistant to alectinib. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Jin, Feng, Chenyang Wang, Fang Yang, Shubin Wang, and Fen Wang. Case Report: Successful Late-line Pralsetinib Treatment in an ALK-rearranged Lung Adenocarcinoma Patient with KIF5B-RET Fusion Resistant to Alectinib. Frontiers Media S.A.

MLA (9th ed.) Citation

Jin, Feng, et al. Case Report: Successful Late-line Pralsetinib Treatment in an ALK-rearranged Lung Adenocarcinoma Patient with KIF5B-RET Fusion Resistant to Alectinib. Frontiers Media S.A.